Child with Hemophilia A presenting claw hand deformity treated with Emicizumabe: excellent clinical result associated to lower financial cost
Objective: Exemplify how prophylaxis using Emicizumabe (EMZ) in children with Hemophilia A can be more effective and less costly than standard management. Patients presenting antibodies against Factor VIII are treated with prophylactic intravenous bypassing medicines, e.g., recombinant Factor VIIa (...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Pukapuka |
| I whakaputaina: |
Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia,
2022-12-01T00:00:00Z.
|
| Ngā marau: | |
| Urunga tuihono: | Connect to this object online. |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ipurangi
Connect to this object online.3rd Floor Main Library
| Tau karanga: |
A1234.567 |
|---|---|
| Tārua 1 | Wātea |